Oral News and Research

RSS

UBC scientists to initiate $4.7M pan-Canadian clinical trial in oral squamous cell cancers

Researchers from the University of British Columbia's Faculties of Medicine, Science and Dentistry are leading a $4.7-million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers.

30 May 2011

Research Roundup: Medicaid co-payments, access to docs causes worse health

Disparities In Child Access To Emergency Care For Acute Oral Injury -- This study looked at the "impact of insurance status on dental practices' willingness to schedule an appointment for a child with a symptomatic fractured permanent front tooth." Six researchers posed as mothers of 10-year-old boys who all had the same injury but different coverage: Medicaid/Children's Health Insurance Program (CHIP) or private Blue Cross dental insurance.

27 May 2011

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Currently, about 30 per cent of patients who receive oral surgery have their cancer recur. But a new, Canada-wide surgical trial using a new approach to remove tumours and pre-cancerous cells from the mouths of those diagnosed with early-stage oral cancer offers new hope for patients.

27 May 2011

Next round of arguments in health law appeals process will be marked by tough questioning

The Obama administration can expect tough questioning from the three appeals judges chosen Wednesday to hear the multi-state challenge to the health care reform law. Unlike the three Democratic appointees who heard the first appeals arguments in Richmond earlier this month, the 11th Circuit panel includes judges appointed by presidents of both parties. The Atlanta-based court is slated to hear appeal arguments June 8.

27 May 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

Long-term exposure to estrogen increases high blood pressure in women

For many years doctors believed the estrogen women consumed in the form of oral contraceptives and hormone replacement therapy pills was good for their patients' hearts. Recent studies however have shown that long-term exposure to estrogen can be a danger to women as it has been associated with high blood pressure, a key link to heart- and brain-attacks.

27 May 2011

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that favorable clinical data on two ImmunoGen-created TAP compounds - IMGN901 and SAR3419 - are being presented at the ASCO 2011 Annual Meeting taking place in Chicago, IL, June 4-8, 2011.

26 May 2011

Nurses can play vital role in increasing patients' adherence to cancer-fighting medication

As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.

26 May 2011

Tofacitinib safe and effective for patients with rheumatoid arthritis

Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.

26 May 2011

Study to examine whether red wine component could help reduce concussions in pro boxers

UT Southwestern Medical Center researchers are engaging the help of professional boxers and trainers to study whether a component in red wine and grapes could help reduce the short- and long-term effects of concussions.

26 May 2011

NIST releases suite of green tea reference materials for manufacturers

The National Institute of Standards and Technology has released a suite of green tea reference materials to help manufacturers evaluate the composition of their products and assure researchers of the accuracy of analytical methods for studying the human health effects of this popular beverage and dietary supplement.

26 May 2011

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced today that new pre-clinical data for its novel, defensin-mimetic antimicrobial compounds was recently presented at two prestigious scientific meetings, including the American Society of Microbiology.

25 May 2011

Biogen Idec joins global multiple sclerosis community to celebrate third annual World MS Day

Today, Biogen Idec will join the global multiple sclerosis (MS) community in celebrating the third annual World MS Day. Biogen Idec continues to be the industry leader in researching and providing groundbreaking therapies for MS. So far in 2011, the company has brought more hope to MS patients through a number of significant milestones.

25 May 2011

Oral and injected steroids appear to be equally effective for sudden hearing loss

A relatively new treatment for sudden hearing loss that involves injecting steroids into the middle ear appears to work just as well as the current standard of oral steroids, a study by researchers at Johns Hopkins and other institutions suggests.

25 May 2011

IOF to host largest clinical bone meeting in Dubai

Healthcare professionals and key opinion leaders from throughout the Middle-East and Africa will gather in Dubai for the largest clinical bone meeting ever held in the region.

25 May 2011

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

The American Academy of Dermatology today reiterated the safety and effectiveness of sunscreens to protect against the damaging effects from exposure to ultraviolet (UV) radiation. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cancer.

24 May 2011

Probiotic bacterial protein could offer new oral therapeutic option for inflammatory bowel disorders

A protein isolated from beneficial bacteria found in yogurt and dairy products could offer a new, oral therapeutic option for inflammatory bowel disorders, suggests a study led by Vanderbilt University Medical Center researcher Fang Yan, M.D., Ph.D.

24 May 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

FDA approves Taro's ANDA for Cetirizine Hydrochloride Oral Solution

Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Cetirizine Hydrochloride Oral Solution, 1 mg/mL.

24 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Oral News and Research

UBC scientists to initiate $4.7M pan-Canadian clinical trial in oral squamous cell cancers

Research Roundup: Medicaid co-payments, access to docs causes worse health

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Next round of arguments in health law appeals process will be marked by tough questioning

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

Long-term exposure to estrogen increases high blood pressure in women

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

Nurses can play vital role in increasing patients' adherence to cancer-fighting medication

Tofacitinib safe and effective for patients with rheumatoid arthritis

Study to examine whether red wine component could help reduce concussions in pro boxers

NIST releases suite of green tea reference materials for manufacturers

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

Biogen Idec joins global multiple sclerosis community to celebrate third annual World MS Day

Oral and injected steroids appear to be equally effective for sudden hearing loss

IOF to host largest clinical bone meeting in Dubai

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

Probiotic bacterial protein could offer new oral therapeutic option for inflammatory bowel disorders

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

FDA approves Taro's ANDA for Cetirizine Hydrochloride Oral Solution

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News